Percutaneous Closure Systems Are Safe in TAVR and Aneurysms

Courtesy of Dr. Carlos Fava.

Currently, one of our medical challenges is to conduct procedures requiring access with large introducer sheaths in a simpler way, without requiring surgical intervention and closing with percutaneous devices while maintaining procedural quality and safety. There are several devices, but they require a learning curve and the only information available comes from small, non-randomized studies.

Cierre percutáneo en fuga paravalvular post TAVIThis study included 221 patients who underwent transcatheter aortic valve replacement (TAVR) and 33 who underwent endoprosthetic thoraco-abdominal aortic aneurysm repair. The percutaneous closure system used was Perclose ProGlide® Suture-Mediated Closure System (Abbott Vascular), which was placed before the procedure so as to conduct a vascular access-site closure after it. Additionally, Glubran 2 was injected after closure for hemostatic control. Moreover, a 0.018” guidewire and a peripheral angioplasty balloon were used through the contralateral access, for hemostasis.

 

The mean age was 82 years; over half the patients were female, 32% had diabetes, and 23.2% had had a prior infarction. The EuroSCORE score was 20.2 ± 2.32. About 78% of the patients had an estimated glomerular filtration rate (e-GFR) <60 mL/min and 3.6% underwent dialysis.


Read also: Amplatzer and Figulla Devices Prove to Be Safe for Percutaneous Patent Foramen Ovale Closure.


The overall success rate of the Perclose ProGlide® plus Glubran 2 access-site closure technique was 98.4%. Four patients (1.6%) required balloon dilation of the closure site after the suture due to the presence of severe stenosis; the strategy was successful.

 

Four patients (1.6%) had minor VARC-2 bleeding events. No patients experienced major VARC-2 bleeding events and no patients required surgery for access-site closure. The time of manual compression was 3.5 ± 1.5 minutes and the total procedure time was 89.35 ± 29.34 minutes.


Read also: Contemporary Results for Septal Embolization in Hypertrophic Cardiomyopathy.


At 30 days, the non-cardiac mortality rate was 0.4% and no patient experienced VARC-2 bleeding.

 

Conclusion

The results of this study suggest that the ProGlide/Glubran technique is a safe and effective method for the closure of transfemoral access-sites after TAVR and thoraco-abdominal aneurysm repair. However, those results need to be confirmed in randomized controlled trials before being adopted in routine clinical practice.

 

Courtesy of Dr. Carlos Fava.

 

Original title: A new Percutaneous technique for effective vascular Access Site closure in patients undergoing Transfemoral aortic valve implantation and thoraco-abdominal aortic aneurysm rEpair: The PASTE Study.

Reference: Giovanni Sorropago et al. EuroIntervention 2018;14: e1278-e1285.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Su opinión nos interesa. Puede dejar su comentario, reflexión, pregunta o lo que desee aquí abajo. Será más que bienvenido.

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...